Acrivon Therapeutics, Inc. (ACRV): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 16, 2026 | Levy Adam D. Officer | 8,832 | $1.70 | $15.0K | no history |
| Jan 16, 2026 | Blume-Jensen Peter Director, Officer | 49,000 | $1.68 | $82.3K | no history |
| Jan 15, 2026 | Devroe Eric Officer | 10,000 | $1.72 | $17.2K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.